Machine Learning-Based Prognostic Signature in Breast Cancer: Regulatory T Cells, Stemness, and Deep Learning for Synergistic Drug Discovery
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26146995 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Samina Gul und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Genetics of Aging & Tumor, Medical School, Kunming University of Science and Technology, 727 Jingming South Road, Kunming 650…. Hauptthemen laut MEDLINE: Breast Neoplasms, T-Lymphocytes, Regulatory, Drug Discovery, Deep Learning. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kunming University of Science and Technology Medical joint project, Special fund project for central government leading local science and technology development.
Abstract (Originalsprache)
Regulatory T cells (Tregs) have multiple roles in the tumor microenvironment (TME), which maintain a balance between autoimmunity and immunosuppression. This research aimed to investigate the interaction between cancer stemness and Regulatory T cells (Tregs) in the breast cancer tumor immune microenvironment. Breast cancer stemness was calculated using one-class logistic regression. Twelve main cell clusters were identified, and the subsequent three subsets of Regulatory T cells with different differentiation states were identified as being closely related to immune regulation and metabolic pathways. A prognostic risk model including MEA1, MTFP1, PASK, PSENEN, PSME2, RCC2, and SH2D2A was generated through the intersection between Regulatory T cell differentiation-related genes and stemness-related genes using LASSO and univariate Cox regression. The patient’s total survival times were predicted and validated with AUC of 0.96 and 0.831 in both training and validation sets, respectively; the immunotherapeutic predication efficacy of prognostic signature was confirmed in four ICI RNA-Seq cohorts. Seven drugs, including Ethinyl Estradiol, Epigallocatechin gallate, Cyclosporine, Gentamicin, Doxorubicin, Ivermectin, and Dronabinol for prognostic signature, were screened through molecular docking and found a synergistic effect among drugs with deep learning. Our prognostic signature potentially paves the way for overcoming immune resistance, and blocking the interaction between cancer stemness and Tregs may be a new approach in the treatment of breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Genetics of Aging & Tumor, Medical School, Kunming University of Science and Technology, 727 Jingming South Road, Kunming 650500, China.
- State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming 650500, China.
- Office of Science and Technology, Yunnan University of Chinese Medicine, Kunming 650500, China.
ORCID-Profile: Yongzhi Chen, Hui Wang, Wenru Tang
Förderung
- Kunming University of Science and Technology Medical joint project
- Special fund project for central government leading local science and technology development
Zitieren
APA
Gul, S., Pang, J., Chen, Y., Qi, Q., Tang, Y., Sun, Y., Wang, H., Tang, W., & Zhou, X. (2025). Machine Learning-Based Prognostic Signature in Breast Cancer: Regulatory T Cells, Stemness, and Deep Learning for Synergistic Drug Discovery. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146995
Vancouver
Gul S, Pang J, Chen Y, Qi Q, Tang Y, Sun Y, et al. Machine Learning-Based Prognostic Signature in Breast Cancer: Regulatory T Cells, Stemness, and Deep Learning for Synergistic Drug Discovery. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146995
BibTeX
@article{Gul2025,
author = {Gul, Samina and Pang, Jianyu and Chen, Yongzhi and Qi, Qi and Tang, Yuheng and Sun, Yingjie and Wang, Hui and Tang, Wenru and Zhou, Xuhong},
title = {Machine Learning-Based Prognostic Signature in Breast Cancer: Regulatory T Cells, Stemness, and Deep Learning for Synergistic Drug Discovery},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26146995}
}
EUVIMED